Patents Assigned to Olkahoma Medical Research Foundation
  • Publication number: 20040175740
    Abstract: Disclosed is a method to identify compounds useful for reducing insulin resistance in a patient, and particularly a patient that has insulin resistance associated with obesity and/or type II diabetes. Also disclosed is a method of reducing insulin resistance in a patient by administering a compound identified using the method of the invention, and particularly, by administering an antagonist of melanocortin stimulating hormone (MSH) biological activity.
    Type: Application
    Filed: January 23, 2004
    Publication date: September 9, 2004
    Applicants: Eleanor Roosevelt Institute, Olkahoma Medical Research Foundation
    Inventors: Miles B. Brennan, Ute Bochgeschwender